Pharmafile Logo
Pharmafocus logo
Advanced Search
jeff_thomas_web

Quintiles president to chair Idis

September 13, 2013
Manufacturing and Production, Research and Development, Sales and Marketing IDIS, Quintiles, thomis

Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …

Appointment
Bayer image

Bayer partners with US academics

September 13, 2013
Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

News
gp image

Hunt: GPs to care for elderly

September 12, 2013
Sales and Marketing GP, Hunt, NHS, elderly

Health secretary Jeremy Hunt says that GPs are in line to become the named clinician responsible for elderly people’s care …

News
Sanofi image

Sanofi withdraws lixisenatide US application

September 12, 2013
Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa

In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …

News
biogen_idec_ten_cambridge_center

Amicus links with Biogen Idec

September 12, 2013
Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …

News
william_cromwell_head_shot_brown

LipoScience reappoints chief medical officer

September 12, 2013
Manufacturing and Production, Research and Development, Sales and Marketing cromwell, liposcience

Diagnostics firm LipoScience has once again hired William Cromwell to be its chief medical officer. He joins the company for …

Appointment

UK trial rules tightened up

September 11, 2013
Research and Development, Sales and Marketing all trials, hra, transparency

Anyone wanting to conduct clinical trials in the UK will have to register their research in order to receive a …

News
astrazeneca image

AstraZeneca pays Merck for cancer drug

September 11, 2013
Sales and Marketing AstraZeneca, Cancer, Merck, WEE1

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …

News
Mike Farrar image

NHS Confederation chief executive quits to be a consultant

September 11, 2013
Medical Communications, Sales and Marketing Mike Farrar, NHS, scandal

Mike Farrar is to stand down as chief executive of the NHS Confederation at the end of the month in …

News
biogen idec image

Biogen signs neurology deal

September 11, 2013
Research and Development, Sales and Marketing Biogen IDEC, Isis, antisense, neurology

Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …

News

Regeneron appoints senior VP from Pfizer

September 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Regeneron, landry

Regeneron Pharmaceuticals has hired Robert Landry from Pfizer to be its senior vice president and chief financial officer.  Landry will …

Appointment
Hospira image

Hospira’s Inflectra approved in Europe

September 10, 2013
Research and Development, Sales and Marketing Hospira, Janssen, Remicade, biosimilars, inflectra

Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …

News
Richard Bergström, EFPIA, all trials, ema

EFPIA slams EMA data proposals

September 10, 2013
Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche

The intense debate over how pharma should make trial data available has taken another turn as a major European industry …

News
GSK image

GSK completes £1.35 billion Suntory deal

September 10, 2013
Sales and Marketing GSK, Suntory, lucozade, ribena

GlaxoSmithKline has confirmed it is to sell Lucozade and Ribena to Japanese drinks giant Suntory Beverage & Food for £1.35 …

News
Capsugel image

Capsugel on the acquisition trail once again

September 10, 2013
Manufacturing and Production Bend Research, Capsugel

Capsugel has agreed to buy US company Bend Research in another transaction that expands its drug delivery division. The deal …

News

J&J’s manufacturing recovery hits a hurdle

September 10, 2013
Manufacturing and Production API, J&J, JJ, McNeil, Motrin, recall

Johnson & Johnson’s path back to regulatory compliance in its manufacturing operations has hit another snag after the firm was …

News
dr_robert_brooks_web

Robert Brooks joins Achilles from Abbott

September 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Abbott, achilles, brook

Supply chain firm Achilles has hired Dr Robert Brooks to be a Business Development director from pharma firm Abbott. Brooks …

Appointment
NHS image

Mid Staffs not only ‘dark spot’ in NHS

September 10, 2013
Medical Communications, Sales and Marketing BMJ, Mid Staffs, NHS

The scandal of poor patient care at the Mid Staffordshire NHS Foundation Trust is likely to be far from an …

News
Merck image

Green light at Merck facility boosts varicella vaccine supplies

September 9, 2013
Manufacturing and Production Merck, Taylor, varicella

Prospects for Merck & Co’s vaccines for shingles and chickenpox have been lifted by approval of additional bulk manufacturing capacity …

News
Gedeon richter image

Gedeon Richter named and shamed

September 9, 2013
Medical Communications, Sales and Marketing ABPI, Gedeon Richter, PMCPA

Gedeon Richter (UK) has been named and shamed in advertisements by the PMCPA, which rules on breaches of the ABPI …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026